Clinical Trials Directory

Trials / Unknown

UnknownNCT05261724

Diffusion-tensor Imaging in Brain Tumors Evaluation

Contribution of Diffusion Tensor Imaging and Tractography in Primary and Secondary Brain Tumors Evaluation

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary and secondary brain tumors are challenging pathologies regarding diagnosis and treatment. MRI is widely used in the imaging evaluation and surgical planning, due to its spatial resolution and ability of tissular characterization. In this study patients with suspected brain tumors, confirmed by routine MRI evaluation (T1, T2, T2\*, FLAIR, T1 with contrast sequences) will undergo DWI and DTI evaluation. By analyzing collected data from MRI evaluation and patient records regarding surgical and histopathological data our aim is to investigate derived imaging biomarkers with impact in the surgical planning and rehabilitation of the patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMRIIn this study patients with suspected primary and secondary brain tumors, confirmed by routine MRI evaluation (T1, T2, T2\*, FLAIR, T1 with contrast sequences) will undergo DWI and DTI evaluation.

Timeline

Start date
2021-02-15
Primary completion
2021-03-14
Completion
2022-03-14
First posted
2022-03-02
Last updated
2022-03-02

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT05261724. Inclusion in this directory is not an endorsement.